Peter Hoffmann

No ORCID on file · 3 papers in corpus
case-report 2020
Frontiers in oncology ·doi:10.3389/fonc.2020.523989

Serous endometrial cancer (SEC) and high grade serous ovarian cancer (HGSOC) are aggressive gynecological malignancies with high rates of metastasis and poor prognosis. Endometrial intraepithelial carcinoma (EIC), the precursor for SEC, and…

review 2012
International journal of molecular sciences ·doi:10.3390/ijms130810568

The ovarian cancer biomarker CA125 has been extensively investigated over the last 30 years. The knowledge about the exact molecular nature of this protein, however, remains fragmented. This review provides an overview of the structural res…

review 2011
International journal of molecular sciences ·doi:10.3390/ijms12010410

Most scientific efforts towards early detection of ovarian cancer are commonly focused on the discovery of tumour-associated antigens (TAA). Autologous antibodies against TAA, however, may serve as more sensitive diagnostic markers. They ci…